Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Personality Disorders: Paranoid and Schizoid

Personality Disorders: Paranoid and Schizoid

Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Personality Disorders: Schizotypal and Histrionic

Personality Disorders: Schizotypal and Histrionic

Schizotypal personality disorder and histrionic personality disorder are two distinct psychological conditions classified under personality disorders, each characterized by unique behavioral patterns and social difficulties. Both disorders significantly affect interpersonal relationships and emotional well-being, leading to social isolation and frustration.
Schizotypal Personality Disorder: Eccentric Behavior and Social Withdrawal
Schizotypal personality disorder is marked by odd or eccentric...

Negative and Cognitive Symptoms of Schizophrenia

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tolerance, physical dependence, and addiction: Knowledge gaps and misconceptions of first-year pharmacy students.

Currents in pharmacy teaching & learning·2023

Same author

Role of spinal GABA receptors in the acute antinociceptive response of mice to hyperbaric oxygen.

Brain research·2018

Same author

Forecasting academic success through implementation of an online prerequisite review tutorials program for first year pharmacy students.

Currents in pharmacy teaching & learning·2017

Same author

An interprofessional case conference on Alzheimer's disease: teaching students in the health professions to work together.

Journal of interprofessional care·2011

Same author

Learning bridge: curricular integration of didactic and experiential education.

American journal of pharmaceutical education·2010

Same author

Electrophysiological heterogeneity of spinally projecting serotonergic and nonserotonergic neurons in the rostral ventromedial medulla.

Journal of neurophysiology·2005

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Peer-level patient presenters decrease pharmacy students' social distance from patients with schizophrenia and

Amber V Buhler¹, Reza M Karimi

¹School of Pharmacy, Pacific University, Hillsboro, OR, 97123, USA. abuhler@pacificu.edu

American Journal of Pharmaceutical Education

|February 14, 2009

Summary

Pharmacy students showed reduced social barriers when interacting with mentally ill patients after a curriculum change. This included improved understanding of schizophrenia and depression, and treatment efficacy.

Keywords:

curriculum depression mental illness schizophrenia social distance

Related Experiment Videos

Last Updated: Jun 25, 2026

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Area of Science:

Medical Education
Psychiatry
Pharmacy Practice

Background:

Social barriers hinder effective treatment of mentally ill patients.
Pharmacy students require specific training to address these barriers.
Curricular interventions are needed to improve patient interaction and care.

Purpose of the Study:

To develop and evaluate a Doctor of Pharmacy (PharmD) curricular experience.
To decrease social barriers faced by students when interacting with and treating mentally ill patients.
To enhance students' understanding of mental illnesses and treatment efficacy.

Main Methods:

A survey instrument was developed to assess students' understanding of schizophrenia and clinical depression.
The survey measured understanding of disease nature, patient behavior, treatment efficacy, and social distance.
The instrument was administered before and after a neuropsychiatry curriculum incorporating peer-level patient presenters.

Main Results:

Significant decrease in social distance scores among first-year pharmacy students.
Increased willingness to interact with individuals diagnosed with schizophrenia and clinical depression.
Enhanced student understanding of illness causes, patient behavior, and the efficacy of drug counseling.

Conclusions:

Curricular modifications, specifically adding peer-level patient presentations, can significantly reduce social barriers.
These changes improve pharmacy students' ability to treat mentally ill patients.
The intervention demonstrates a quantitative decrease in social distance, promoting better patient care.